| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 142, 1641-1653, Copyright © 1993 by American Society for Investigative Pathology
REGULAR ARTICLES |
CI Whiteside, R Cameron, S Munk and J Levy
Department of Medicine, University of Toronto, Ontario, Canada.
Puromycin aminonucleoside--(PAN) treated rats develop acute nephrotic syndrome, mimicking human minimal lesion disease. In PAN nephrosis, podocyte detachment from the glomerular basement membrane (GBM) is the most likely cause of massive proteinuria in this model. To elucidate further the mechanisms of PAN-induced cellular dysfunction, new methods were employed to visualize podocyte cytoskeletal aggregation and to measure fibrillar attachment to the GBM. Adult Sprague-Dawley rats (n = 4/group) received a single tail-vein injection of PAN (75 mg/kg). On days 1, 2, 3, and 5 following injection, 24-hour urine collections were obtained for creatinine clearance, albuminuria, and total proteinuria. Then kidneys from each group were fixed by perfusion. Podocytic cytoskeleton was visualized by scanning electron microscopy. Subepithelial GBM staining and attachment fiber number, observed on digitized images of transmission electron micrographs, were quantitated with computer-based density analysis. A significant reduction in attachment fiber number in the GBM lamina rara externa occurred by day 5. On scanning electron micrographs, the secondary and tertiary podocytic processes were observed to be formed by highly aggregated cytoskeleton, which became partially disaggregated by day 3, was totally absent by day 5, and normalized by day 20. Immunogold staining revealed that actin and vinculin localized to the tertiary podocytic processes in the normal state were dispersed into the cell body following PAN. Podocyte cytoskeletal disaggregation precedes, and detachment from the GBM occurs simultaneously with, the onset of massive proteinuria in the PAN model.
This article has been cited by other articles:
![]() |
A.-L. Sellier-Leclerc, A. Duval, S. Riveron, M.-A. Macher, G. Deschenes, C. Loirat, M.-C. Verpont, M. Peuchmaur, P. Ronco, R. C. Monteiro, et al. A Humanized Mouse Model of Idiopathic Nephrotic Syndrome Suggests a Pathogenic Role for Immature Cells J. Am. Soc. Nephrol., October 1, 2007; 18(10): 2732 - 2739. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Toyoda, B. Najafian, Y. Kim, M. L. Caramori, and M. Mauer Podocyte Detachment and Reduced Glomerular Capillary Endothelial Fenestration in Human Type 1 Diabetic Nephropathy Diabetes, August 1, 2007; 56(8): 2155 - 2160. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Macconi, M. Abbate, M. Morigi, S. Angioletti, M. Mister, S. Buelli, M. Bonomelli, P. Mundel, K. Endlich, A. Remuzzi, et al. Permselective Dysfunction of Podocyte-Podocyte Contact upon Angiotensin II Unravels the Molecular Target for Renoprotective Intervention Am. J. Pathol., April 1, 2006; 168(4): 1073 - 1085. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Shibata, M. Nagase, and T. Fujita Fluvastatin Ameliorates Podocyte Injury in Proteinuric Rats via Modulation of Excessive Rho Signaling J. Am. Soc. Nephrol., March 1, 2006; 17(3): 754 - 764. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Macconi, M. Bonomelli, A. Benigni, T. Plati, F. Sangalli, L. Longaretti, S. Conti, H. Kawachi, P. Hill, G. Remuzzi, et al. Pathophysiologic Implications of Reduced Podocyte Number in a Rat Model of Progressive Glomerular Injury Am. J. Pathol., January 1, 2006; 168(1): 42 - 54. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Schmieder, M. Nagai, R. A. Orlando, T. Takeda, and M. G. Farquhar Podocalyxin Activates RhoA and Induces Actin Reorganization through NHERF1 and Ezrin in MDCK Cells J. Am. Soc. Nephrol., September 1, 2004; 15(9): 2289 - 2298. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Martineau, L. I. McVeigh, B. J. Jasmin, and C. R. J. Kennedy p38 MAP kinase mediates mechanically induced COX-2 and PG EP4 receptor expression in podocytes: implications for the actin cytoskeleton Am J Physiol Renal Physiol, April 1, 2004; 286(4): F693 - F701. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-L. Michaud, L. I. Lemieux, M. Dube, B. C. Vanderhyden, S. J. Robertson, and C. R.J. Kennedy Focal and Segmental Glomerulosclerosis in Mice with Podocyte-Specific Expression of Mutant {alpha}-Actinin-4 J. Am. Soc. Nephrol., May 1, 2003; 14(5): 1200 - 1211. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Pavenstadt, W. Kriz, and M. Kretzler Cell Biology of the Glomerular Podocyte Physiol Rev, January 1, 2003; 83(1): 253 - 307. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Boucherot, R. Schreiber, H. Pavenstadt, and K. Kunzelmann Cloning and expression of the mouse glomerular podoplanin homologue gp38P Nephrol. Dial. Transplant., June 1, 2002; 17(6): 978 - 984. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Davidson, R. Dono, and R. Zeller FGF signalling is required for differentiation-induced cytoskeletal reorganisation and formation of actin-based processes by podocytes J. Cell Sci., March 11, 2002; 114(18): 3359 - 3366. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Huh, D. J. Kim, M.-K. Kim, Y. G. Kim, H.-Y. Oh, V. Ruotsalainen, and K. Tryggvason Expression of nephrin in acquired human glomerular disease Nephrol. Dial. Transplant., March 1, 2002; 17(3): 478 - 484. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. E. SMOYER and R. F. RANSOM Hsp27 regulates podocyte cytoskeletal changes in an in vitro model of podocyte process retraction FASEB J, March 1, 2002; 16(3): 315 - 326. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Greive, D. J. Nikolic-Paterson, M. A. M. Guimaraes, J. Nikolovski, L. M. Pratt, W. Mu, R. C. Atkins, and W. D. Comper Glomerular Permselectivity Factors Are Not Responsible for the Increase in Fractional Clearance of Albumin in Rat Glomerulonephritis Am. J. Pathol., September 1, 2001; 159(3): 1159 - 1170. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Nagasawa, M. Takenaka, J. Kaimori, Y. Matsuoka, Y. Akagi, M. Tsujie, E. Imai, and M. Hori Rapid and diverse changes of gene expression in the kidneys of protein-overload proteinuria mice detected by microarray analysis Nephrol. Dial. Transplant., May 1, 2001; 16(5): 923 - 931. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gloy, S. Reitinger, K.-G. Fischer, R. Schreiber, A. Boucherot, K. Kunzelmann, P. Mundel, and H. Pavenstadt Amino acid transport in podocytes Am J Physiol Renal Physiol, June 1, 2000; 278(6): F999 - F1005. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Kershaw, P. E. Thomas, B. L. Wharram, M. Goyal, J. E. Wiggins, C. I. Whiteside, and R. C. Wiggins Molecular Cloning, Expression, and Characterization of Podocalyxin-like Protein 1 from Rabbit as a Transmembrane Protein of Glomerular Podocytes and Vascular Endothelium J. Biol. Chem., December 8, 1995; 270(49): 29439 - 29446. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |